Global Genetically Modified Drug Supply, Demand and Key Producers, 2023-2029
The global Genetically Modified Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Drugs made by genetically modified means are also called 'biological drugs'
This report studies the global Genetically Modified Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genetically Modified Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genetically Modified Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Genetically Modified Drug total production and demand, 2018-2029, (K Units)
Global Genetically Modified Drug total production value, 2018-2029, (USD Million)
Global Genetically Modified Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Genetically Modified Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Genetically Modified Drug domestic production, consumption, key domestic manufacturers and share
Global Genetically Modified Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Genetically Modified Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Genetically Modified Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Genetically Modified Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include LFB Biotechnologies SA, Pharming Group NV, Pfizer, Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Amgen and F. Hoffmann-La Roche, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Genetically Modified Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Genetically Modified Drug Market, By Region:
1. How big is the global Genetically Modified Drug market?
2. What is the demand of the global Genetically Modified Drug market?
3. What is the year over year growth of the global Genetically Modified Drug market?
4. What is the production and production value of the global Genetically Modified Drug market?
5. Who are the key producers in the global Genetically Modified Drug market?
6. What are the growth factors driving the market demand?
Drugs made by genetically modified means are also called 'biological drugs'
This report studies the global Genetically Modified Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genetically Modified Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genetically Modified Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Genetically Modified Drug total production and demand, 2018-2029, (K Units)
Global Genetically Modified Drug total production value, 2018-2029, (USD Million)
Global Genetically Modified Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Genetically Modified Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Genetically Modified Drug domestic production, consumption, key domestic manufacturers and share
Global Genetically Modified Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Genetically Modified Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Genetically Modified Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Genetically Modified Drug market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include LFB Biotechnologies SA, Pharming Group NV, Pfizer, Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Amgen and F. Hoffmann-La Roche, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Genetically Modified Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Genetically Modified Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Transgenic Animal
- Transgenic Plant
- Hospital
- Clinic
- LFB Biotechnologies SA
- Pharming Group NV
- Pfizer
- Roche
- Abbott Laboratories
- Johnson & Johnson
- Merck & Co.
- Amgen
- F. Hoffmann-La Roche
- Sanofi
- Novartis
- Eli Lilly
- Takeda
- Baxter
- GlaxoSmithKline
1. How big is the global Genetically Modified Drug market?
2. What is the demand of the global Genetically Modified Drug market?
3. What is the year over year growth of the global Genetically Modified Drug market?
4. What is the production and production value of the global Genetically Modified Drug market?
5. Who are the key producers in the global Genetically Modified Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Genetically Modified Drug Introduction
1.2 World Genetically Modified Drug Supply & Forecast
1.2.1 World Genetically Modified Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Genetically Modified Drug Production (2018-2029)
1.2.3 World Genetically Modified Drug Pricing Trends (2018-2029)
1.3 World Genetically Modified Drug Production by Region (Based on Production Site)
1.3.1 World Genetically Modified Drug Production Value by Region (2018-2029)
1.3.2 World Genetically Modified Drug Production by Region (2018-2029)
1.3.3 World Genetically Modified Drug Average Price by Region (2018-2029)
1.3.4 North America Genetically Modified Drug Production (2018-2029)
1.3.5 Europe Genetically Modified Drug Production (2018-2029)
1.3.6 China Genetically Modified Drug Production (2018-2029)
1.3.7 Japan Genetically Modified Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genetically Modified Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Genetically Modified Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Genetically Modified Drug Demand (2018-2029)
2.2 World Genetically Modified Drug Consumption by Region
2.2.1 World Genetically Modified Drug Consumption by Region (2018-2023)
2.2.2 World Genetically Modified Drug Consumption Forecast by Region (2024-2029)
2.3 United States Genetically Modified Drug Consumption (2018-2029)
2.4 China Genetically Modified Drug Consumption (2018-2029)
2.5 Europe Genetically Modified Drug Consumption (2018-2029)
2.6 Japan Genetically Modified Drug Consumption (2018-2029)
2.7 South Korea Genetically Modified Drug Consumption (2018-2029)
2.8 ASEAN Genetically Modified Drug Consumption (2018-2029)
2.9 India Genetically Modified Drug Consumption (2018-2029)
3 WORLD GENETICALLY MODIFIED DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Genetically Modified Drug Production Value by Manufacturer (2018-2023)
3.2 World Genetically Modified Drug Production by Manufacturer (2018-2023)
3.3 World Genetically Modified Drug Average Price by Manufacturer (2018-2023)
3.4 Genetically Modified Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Genetically Modified Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Genetically Modified Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Genetically Modified Drug in 2022
3.6 Genetically Modified Drug Market: Overall Company Footprint Analysis
3.6.1 Genetically Modified Drug Market: Region Footprint
3.6.2 Genetically Modified Drug Market: Company Product Type Footprint
3.6.3 Genetically Modified Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Genetically Modified Drug Production Value Comparison
4.1.1 United States VS China: Genetically Modified Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Genetically Modified Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Genetically Modified Drug Production Comparison
4.2.1 United States VS China: Genetically Modified Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Genetically Modified Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Genetically Modified Drug Consumption Comparison
4.3.1 United States VS China: Genetically Modified Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Genetically Modified Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Genetically Modified Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Genetically Modified Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Genetically Modified Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Genetically Modified Drug Production (2018-2023)
4.5 China Based Genetically Modified Drug Manufacturers and Market Share
4.5.1 China Based Genetically Modified Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Genetically Modified Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Genetically Modified Drug Production (2018-2023)
4.6 Rest of World Based Genetically Modified Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Genetically Modified Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Genetically Modified Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Genetically Modified Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Genetically Modified Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Transgenic Animal
5.2.2 Transgenic Plant
5.3 Market Segment by Type
5.3.1 World Genetically Modified Drug Production by Type (2018-2029)
5.3.2 World Genetically Modified Drug Production Value by Type (2018-2029)
5.3.3 World Genetically Modified Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Genetically Modified Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Genetically Modified Drug Production by Application (2018-2029)
6.3.2 World Genetically Modified Drug Production Value by Application (2018-2029)
6.3.3 World Genetically Modified Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 LFB Biotechnologies SA
7.1.1 LFB Biotechnologies SA Details
7.1.2 LFB Biotechnologies SA Major Business
7.1.3 LFB Biotechnologies SA Genetically Modified Drug Product and Services
7.1.4 LFB Biotechnologies SA Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 LFB Biotechnologies SA Recent Developments/Updates
7.1.6 LFB Biotechnologies SA Competitive Strengths & Weaknesses
7.2 Pharming Group NV
7.2.1 Pharming Group NV Details
7.2.2 Pharming Group NV Major Business
7.2.3 Pharming Group NV Genetically Modified Drug Product and Services
7.2.4 Pharming Group NV Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Pharming Group NV Recent Developments/Updates
7.2.6 Pharming Group NV Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer Genetically Modified Drug Product and Services
7.3.4 Pfizer Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Roche
7.4.1 Roche Details
7.4.2 Roche Major Business
7.4.3 Roche Genetically Modified Drug Product and Services
7.4.4 Roche Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Roche Recent Developments/Updates
7.4.6 Roche Competitive Strengths & Weaknesses
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Details
7.5.2 Abbott Laboratories Major Business
7.5.3 Abbott Laboratories Genetically Modified Drug Product and Services
7.5.4 Abbott Laboratories Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Abbott Laboratories Recent Developments/Updates
7.5.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Details
7.6.2 Johnson & Johnson Major Business
7.6.3 Johnson & Johnson Genetically Modified Drug Product and Services
7.6.4 Johnson & Johnson Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Johnson & Johnson Recent Developments/Updates
7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.7 Merck & Co.
7.7.1 Merck & Co. Details
7.7.2 Merck & Co. Major Business
7.7.3 Merck & Co. Genetically Modified Drug Product and Services
7.7.4 Merck & Co. Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Merck & Co. Recent Developments/Updates
7.7.6 Merck & Co. Competitive Strengths & Weaknesses
7.8 Amgen
7.8.1 Amgen Details
7.8.2 Amgen Major Business
7.8.3 Amgen Genetically Modified Drug Product and Services
7.8.4 Amgen Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Amgen Recent Developments/Updates
7.8.6 Amgen Competitive Strengths & Weaknesses
7.9 F. Hoffmann-La Roche
7.9.1 F. Hoffmann-La Roche Details
7.9.2 F. Hoffmann-La Roche Major Business
7.9.3 F. Hoffmann-La Roche Genetically Modified Drug Product and Services
7.9.4 F. Hoffmann-La Roche Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 F. Hoffmann-La Roche Recent Developments/Updates
7.9.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
7.10 Sanofi
7.10.1 Sanofi Details
7.10.2 Sanofi Major Business
7.10.3 Sanofi Genetically Modified Drug Product and Services
7.10.4 Sanofi Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sanofi Recent Developments/Updates
7.10.6 Sanofi Competitive Strengths & Weaknesses
7.11 Novartis
7.11.1 Novartis Details
7.11.2 Novartis Major Business
7.11.3 Novartis Genetically Modified Drug Product and Services
7.11.4 Novartis Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Novartis Recent Developments/Updates
7.11.6 Novartis Competitive Strengths & Weaknesses
7.12 Eli Lilly
7.12.1 Eli Lilly Details
7.12.2 Eli Lilly Major Business
7.12.3 Eli Lilly Genetically Modified Drug Product and Services
7.12.4 Eli Lilly Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Eli Lilly Recent Developments/Updates
7.12.6 Eli Lilly Competitive Strengths & Weaknesses
7.13 Takeda
7.13.1 Takeda Details
7.13.2 Takeda Major Business
7.13.3 Takeda Genetically Modified Drug Product and Services
7.13.4 Takeda Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Takeda Recent Developments/Updates
7.13.6 Takeda Competitive Strengths & Weaknesses
7.14 Baxter
7.14.1 Baxter Details
7.14.2 Baxter Major Business
7.14.3 Baxter Genetically Modified Drug Product and Services
7.14.4 Baxter Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Baxter Recent Developments/Updates
7.14.6 Baxter Competitive Strengths & Weaknesses
7.15 GlaxoSmithKline
7.15.1 GlaxoSmithKline Details
7.15.2 GlaxoSmithKline Major Business
7.15.3 GlaxoSmithKline Genetically Modified Drug Product and Services
7.15.4 GlaxoSmithKline Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 GlaxoSmithKline Recent Developments/Updates
7.15.6 GlaxoSmithKline Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Genetically Modified Drug Industry Chain
8.2 Genetically Modified Drug Upstream Analysis
8.2.1 Genetically Modified Drug Core Raw Materials
8.2.2 Main Manufacturers of Genetically Modified Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Genetically Modified Drug Production Mode
8.6 Genetically Modified Drug Procurement Model
8.7 Genetically Modified Drug Industry Sales Model and Sales Channels
8.7.1 Genetically Modified Drug Sales Model
8.7.2 Genetically Modified Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Genetically Modified Drug Introduction
1.2 World Genetically Modified Drug Supply & Forecast
1.2.1 World Genetically Modified Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Genetically Modified Drug Production (2018-2029)
1.2.3 World Genetically Modified Drug Pricing Trends (2018-2029)
1.3 World Genetically Modified Drug Production by Region (Based on Production Site)
1.3.1 World Genetically Modified Drug Production Value by Region (2018-2029)
1.3.2 World Genetically Modified Drug Production by Region (2018-2029)
1.3.3 World Genetically Modified Drug Average Price by Region (2018-2029)
1.3.4 North America Genetically Modified Drug Production (2018-2029)
1.3.5 Europe Genetically Modified Drug Production (2018-2029)
1.3.6 China Genetically Modified Drug Production (2018-2029)
1.3.7 Japan Genetically Modified Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genetically Modified Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Genetically Modified Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Genetically Modified Drug Demand (2018-2029)
2.2 World Genetically Modified Drug Consumption by Region
2.2.1 World Genetically Modified Drug Consumption by Region (2018-2023)
2.2.2 World Genetically Modified Drug Consumption Forecast by Region (2024-2029)
2.3 United States Genetically Modified Drug Consumption (2018-2029)
2.4 China Genetically Modified Drug Consumption (2018-2029)
2.5 Europe Genetically Modified Drug Consumption (2018-2029)
2.6 Japan Genetically Modified Drug Consumption (2018-2029)
2.7 South Korea Genetically Modified Drug Consumption (2018-2029)
2.8 ASEAN Genetically Modified Drug Consumption (2018-2029)
2.9 India Genetically Modified Drug Consumption (2018-2029)
3 WORLD GENETICALLY MODIFIED DRUG MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Genetically Modified Drug Production Value by Manufacturer (2018-2023)
3.2 World Genetically Modified Drug Production by Manufacturer (2018-2023)
3.3 World Genetically Modified Drug Average Price by Manufacturer (2018-2023)
3.4 Genetically Modified Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Genetically Modified Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Genetically Modified Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Genetically Modified Drug in 2022
3.6 Genetically Modified Drug Market: Overall Company Footprint Analysis
3.6.1 Genetically Modified Drug Market: Region Footprint
3.6.2 Genetically Modified Drug Market: Company Product Type Footprint
3.6.3 Genetically Modified Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Genetically Modified Drug Production Value Comparison
4.1.1 United States VS China: Genetically Modified Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Genetically Modified Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Genetically Modified Drug Production Comparison
4.2.1 United States VS China: Genetically Modified Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Genetically Modified Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Genetically Modified Drug Consumption Comparison
4.3.1 United States VS China: Genetically Modified Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Genetically Modified Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Genetically Modified Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Genetically Modified Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Genetically Modified Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Genetically Modified Drug Production (2018-2023)
4.5 China Based Genetically Modified Drug Manufacturers and Market Share
4.5.1 China Based Genetically Modified Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Genetically Modified Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Genetically Modified Drug Production (2018-2023)
4.6 Rest of World Based Genetically Modified Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Genetically Modified Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Genetically Modified Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Genetically Modified Drug Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Genetically Modified Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Transgenic Animal
5.2.2 Transgenic Plant
5.3 Market Segment by Type
5.3.1 World Genetically Modified Drug Production by Type (2018-2029)
5.3.2 World Genetically Modified Drug Production Value by Type (2018-2029)
5.3.3 World Genetically Modified Drug Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Genetically Modified Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Genetically Modified Drug Production by Application (2018-2029)
6.3.2 World Genetically Modified Drug Production Value by Application (2018-2029)
6.3.3 World Genetically Modified Drug Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 LFB Biotechnologies SA
7.1.1 LFB Biotechnologies SA Details
7.1.2 LFB Biotechnologies SA Major Business
7.1.3 LFB Biotechnologies SA Genetically Modified Drug Product and Services
7.1.4 LFB Biotechnologies SA Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 LFB Biotechnologies SA Recent Developments/Updates
7.1.6 LFB Biotechnologies SA Competitive Strengths & Weaknesses
7.2 Pharming Group NV
7.2.1 Pharming Group NV Details
7.2.2 Pharming Group NV Major Business
7.2.3 Pharming Group NV Genetically Modified Drug Product and Services
7.2.4 Pharming Group NV Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Pharming Group NV Recent Developments/Updates
7.2.6 Pharming Group NV Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer Genetically Modified Drug Product and Services
7.3.4 Pfizer Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Roche
7.4.1 Roche Details
7.4.2 Roche Major Business
7.4.3 Roche Genetically Modified Drug Product and Services
7.4.4 Roche Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Roche Recent Developments/Updates
7.4.6 Roche Competitive Strengths & Weaknesses
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Details
7.5.2 Abbott Laboratories Major Business
7.5.3 Abbott Laboratories Genetically Modified Drug Product and Services
7.5.4 Abbott Laboratories Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Abbott Laboratories Recent Developments/Updates
7.5.6 Abbott Laboratories Competitive Strengths & Weaknesses
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Details
7.6.2 Johnson & Johnson Major Business
7.6.3 Johnson & Johnson Genetically Modified Drug Product and Services
7.6.4 Johnson & Johnson Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Johnson & Johnson Recent Developments/Updates
7.6.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.7 Merck & Co.
7.7.1 Merck & Co. Details
7.7.2 Merck & Co. Major Business
7.7.3 Merck & Co. Genetically Modified Drug Product and Services
7.7.4 Merck & Co. Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Merck & Co. Recent Developments/Updates
7.7.6 Merck & Co. Competitive Strengths & Weaknesses
7.8 Amgen
7.8.1 Amgen Details
7.8.2 Amgen Major Business
7.8.3 Amgen Genetically Modified Drug Product and Services
7.8.4 Amgen Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Amgen Recent Developments/Updates
7.8.6 Amgen Competitive Strengths & Weaknesses
7.9 F. Hoffmann-La Roche
7.9.1 F. Hoffmann-La Roche Details
7.9.2 F. Hoffmann-La Roche Major Business
7.9.3 F. Hoffmann-La Roche Genetically Modified Drug Product and Services
7.9.4 F. Hoffmann-La Roche Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 F. Hoffmann-La Roche Recent Developments/Updates
7.9.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
7.10 Sanofi
7.10.1 Sanofi Details
7.10.2 Sanofi Major Business
7.10.3 Sanofi Genetically Modified Drug Product and Services
7.10.4 Sanofi Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Sanofi Recent Developments/Updates
7.10.6 Sanofi Competitive Strengths & Weaknesses
7.11 Novartis
7.11.1 Novartis Details
7.11.2 Novartis Major Business
7.11.3 Novartis Genetically Modified Drug Product and Services
7.11.4 Novartis Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Novartis Recent Developments/Updates
7.11.6 Novartis Competitive Strengths & Weaknesses
7.12 Eli Lilly
7.12.1 Eli Lilly Details
7.12.2 Eli Lilly Major Business
7.12.3 Eli Lilly Genetically Modified Drug Product and Services
7.12.4 Eli Lilly Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Eli Lilly Recent Developments/Updates
7.12.6 Eli Lilly Competitive Strengths & Weaknesses
7.13 Takeda
7.13.1 Takeda Details
7.13.2 Takeda Major Business
7.13.3 Takeda Genetically Modified Drug Product and Services
7.13.4 Takeda Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Takeda Recent Developments/Updates
7.13.6 Takeda Competitive Strengths & Weaknesses
7.14 Baxter
7.14.1 Baxter Details
7.14.2 Baxter Major Business
7.14.3 Baxter Genetically Modified Drug Product and Services
7.14.4 Baxter Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Baxter Recent Developments/Updates
7.14.6 Baxter Competitive Strengths & Weaknesses
7.15 GlaxoSmithKline
7.15.1 GlaxoSmithKline Details
7.15.2 GlaxoSmithKline Major Business
7.15.3 GlaxoSmithKline Genetically Modified Drug Product and Services
7.15.4 GlaxoSmithKline Genetically Modified Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 GlaxoSmithKline Recent Developments/Updates
7.15.6 GlaxoSmithKline Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Genetically Modified Drug Industry Chain
8.2 Genetically Modified Drug Upstream Analysis
8.2.1 Genetically Modified Drug Core Raw Materials
8.2.2 Main Manufacturers of Genetically Modified Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Genetically Modified Drug Production Mode
8.6 Genetically Modified Drug Procurement Model
8.7 Genetically Modified Drug Industry Sales Model and Sales Channels
8.7.1 Genetically Modified Drug Sales Model
8.7.2 Genetically Modified Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Genetically Modified Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Genetically Modified Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Genetically Modified Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Genetically Modified Drug Production Value Market Share by Region (2018-2023)
Table 5. World Genetically Modified Drug Production Value Market Share by Region (2024-2029)
Table 6. World Genetically Modified Drug Production by Region (2018-2023) & (K Units)
Table 7. World Genetically Modified Drug Production by Region (2024-2029) & (K Units)
Table 8. World Genetically Modified Drug Production Market Share by Region (2018-2023)
Table 9. World Genetically Modified Drug Production Market Share by Region (2024-2029)
Table 10. World Genetically Modified Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Genetically Modified Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Genetically Modified Drug Major Market Trends
Table 13. World Genetically Modified Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Genetically Modified Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Genetically Modified Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Genetically Modified Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Genetically Modified Drug Producers in 2022
Table 18. World Genetically Modified Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Genetically Modified Drug Producers in 2022
Table 20. World Genetically Modified Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Genetically Modified Drug Company Evaluation Quadrant
Table 22. World Genetically Modified Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Genetically Modified Drug Production Site of Key Manufacturer
Table 24. Genetically Modified Drug Market: Company Product Type Footprint
Table 25. Genetically Modified Drug Market: Company Product Application Footprint
Table 26. Genetically Modified Drug Competitive Factors
Table 27. Genetically Modified Drug New Entrant and Capacity Expansion Plans
Table 28. Genetically Modified Drug Mergers & Acquisitions Activity
Table 29. United States VS China Genetically Modified Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Genetically Modified Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Genetically Modified Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Genetically Modified Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Genetically Modified Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Genetically Modified Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Genetically Modified Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Genetically Modified Drug Production Market Share (2018-2023)
Table 37. China Based Genetically Modified Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Genetically Modified Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Genetically Modified Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Genetically Modified Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Genetically Modified Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Genetically Modified Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Genetically Modified Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Genetically Modified Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Genetically Modified Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Genetically Modified Drug Production Market Share (2018-2023)
Table 47. World Genetically Modified Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Genetically Modified Drug Production by Type (2018-2023) & (K Units)
Table 49. World Genetically Modified Drug Production by Type (2024-2029) & (K Units)
Table 50. World Genetically Modified Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Genetically Modified Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Genetically Modified Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Genetically Modified Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Genetically Modified Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Genetically Modified Drug Production by Application (2018-2023) & (K Units)
Table 56. World Genetically Modified Drug Production by Application (2024-2029) & (K Units)
Table 57. World Genetically Modified Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Genetically Modified Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Genetically Modified Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Genetically Modified Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. LFB Biotechnologies SA Basic Information, Manufacturing Base and Competitors
Table 62. LFB Biotechnologies SA Major Business
Table 63. LFB Biotechnologies SA Genetically Modified Drug Product and Services
Table 64. LFB Biotechnologies SA Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. LFB Biotechnologies SA Recent Developments/Updates
Table 66. LFB Biotechnologies SA Competitive Strengths & Weaknesses
Table 67. Pharming Group NV Basic Information, Manufacturing Base and Competitors
Table 68. Pharming Group NV Major Business
Table 69. Pharming Group NV Genetically Modified Drug Product and Services
Table 70. Pharming Group NV Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Pharming Group NV Recent Developments/Updates
Table 72. Pharming Group NV Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer Genetically Modified Drug Product and Services
Table 76. Pfizer Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Pfizer Competitive Strengths & Weaknesses
Table 79. Roche Basic Information, Manufacturing Base and Competitors
Table 80. Roche Major Business
Table 81. Roche Genetically Modified Drug Product and Services
Table 82. Roche Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Roche Recent Developments/Updates
Table 84. Roche Competitive Strengths & Weaknesses
Table 85. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 86. Abbott Laboratories Major Business
Table 87. Abbott Laboratories Genetically Modified Drug Product and Services
Table 88. Abbott Laboratories Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Abbott Laboratories Recent Developments/Updates
Table 90. Abbott Laboratories Competitive Strengths & Weaknesses
Table 91. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 92. Johnson & Johnson Major Business
Table 93. Johnson & Johnson Genetically Modified Drug Product and Services
Table 94. Johnson & Johnson Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Johnson & Johnson Recent Developments/Updates
Table 96. Johnson & Johnson Competitive Strengths & Weaknesses
Table 97. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 98. Merck & Co. Major Business
Table 99. Merck & Co. Genetically Modified Drug Product and Services
Table 100. Merck & Co. Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Merck & Co. Recent Developments/Updates
Table 102. Merck & Co. Competitive Strengths & Weaknesses
Table 103. Amgen Basic Information, Manufacturing Base and Competitors
Table 104. Amgen Major Business
Table 105. Amgen Genetically Modified Drug Product and Services
Table 106. Amgen Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Amgen Recent Developments/Updates
Table 108. Amgen Competitive Strengths & Weaknesses
Table 109. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 110. F. Hoffmann-La Roche Major Business
Table 111. F. Hoffmann-La Roche Genetically Modified Drug Product and Services
Table 112. F. Hoffmann-La Roche Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. F. Hoffmann-La Roche Recent Developments/Updates
Table 114. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
Table 115. Sanofi Basic Information, Manufacturing Base and Competitors
Table 116. Sanofi Major Business
Table 117. Sanofi Genetically Modified Drug Product and Services
Table 118. Sanofi Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sanofi Recent Developments/Updates
Table 120. Sanofi Competitive Strengths & Weaknesses
Table 121. Novartis Basic Information, Manufacturing Base and Competitors
Table 122. Novartis Major Business
Table 123. Novartis Genetically Modified Drug Product and Services
Table 124. Novartis Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Novartis Recent Developments/Updates
Table 126. Novartis Competitive Strengths & Weaknesses
Table 127. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 128. Eli Lilly Major Business
Table 129. Eli Lilly Genetically Modified Drug Product and Services
Table 130. Eli Lilly Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Eli Lilly Recent Developments/Updates
Table 132. Eli Lilly Competitive Strengths & Weaknesses
Table 133. Takeda Basic Information, Manufacturing Base and Competitors
Table 134. Takeda Major Business
Table 135. Takeda Genetically Modified Drug Product and Services
Table 136. Takeda Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Takeda Recent Developments/Updates
Table 138. Takeda Competitive Strengths & Weaknesses
Table 139. Baxter Basic Information, Manufacturing Base and Competitors
Table 140. Baxter Major Business
Table 141. Baxter Genetically Modified Drug Product and Services
Table 142. Baxter Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Baxter Recent Developments/Updates
Table 144. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 145. GlaxoSmithKline Major Business
Table 146. GlaxoSmithKline Genetically Modified Drug Product and Services
Table 147. GlaxoSmithKline Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Genetically Modified Drug Upstream (Raw Materials)
Table 149. Genetically Modified Drug Typical Customers
Table 150. Genetically Modified Drug Typical Distributors
Table 1. World Genetically Modified Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Genetically Modified Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Genetically Modified Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Genetically Modified Drug Production Value Market Share by Region (2018-2023)
Table 5. World Genetically Modified Drug Production Value Market Share by Region (2024-2029)
Table 6. World Genetically Modified Drug Production by Region (2018-2023) & (K Units)
Table 7. World Genetically Modified Drug Production by Region (2024-2029) & (K Units)
Table 8. World Genetically Modified Drug Production Market Share by Region (2018-2023)
Table 9. World Genetically Modified Drug Production Market Share by Region (2024-2029)
Table 10. World Genetically Modified Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Genetically Modified Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Genetically Modified Drug Major Market Trends
Table 13. World Genetically Modified Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Genetically Modified Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Genetically Modified Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Genetically Modified Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Genetically Modified Drug Producers in 2022
Table 18. World Genetically Modified Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Genetically Modified Drug Producers in 2022
Table 20. World Genetically Modified Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Genetically Modified Drug Company Evaluation Quadrant
Table 22. World Genetically Modified Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Genetically Modified Drug Production Site of Key Manufacturer
Table 24. Genetically Modified Drug Market: Company Product Type Footprint
Table 25. Genetically Modified Drug Market: Company Product Application Footprint
Table 26. Genetically Modified Drug Competitive Factors
Table 27. Genetically Modified Drug New Entrant and Capacity Expansion Plans
Table 28. Genetically Modified Drug Mergers & Acquisitions Activity
Table 29. United States VS China Genetically Modified Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Genetically Modified Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Genetically Modified Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Genetically Modified Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Genetically Modified Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Genetically Modified Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Genetically Modified Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Genetically Modified Drug Production Market Share (2018-2023)
Table 37. China Based Genetically Modified Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Genetically Modified Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Genetically Modified Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Genetically Modified Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Genetically Modified Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Genetically Modified Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Genetically Modified Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Genetically Modified Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Genetically Modified Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Genetically Modified Drug Production Market Share (2018-2023)
Table 47. World Genetically Modified Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Genetically Modified Drug Production by Type (2018-2023) & (K Units)
Table 49. World Genetically Modified Drug Production by Type (2024-2029) & (K Units)
Table 50. World Genetically Modified Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Genetically Modified Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Genetically Modified Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Genetically Modified Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Genetically Modified Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Genetically Modified Drug Production by Application (2018-2023) & (K Units)
Table 56. World Genetically Modified Drug Production by Application (2024-2029) & (K Units)
Table 57. World Genetically Modified Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Genetically Modified Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Genetically Modified Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Genetically Modified Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. LFB Biotechnologies SA Basic Information, Manufacturing Base and Competitors
Table 62. LFB Biotechnologies SA Major Business
Table 63. LFB Biotechnologies SA Genetically Modified Drug Product and Services
Table 64. LFB Biotechnologies SA Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. LFB Biotechnologies SA Recent Developments/Updates
Table 66. LFB Biotechnologies SA Competitive Strengths & Weaknesses
Table 67. Pharming Group NV Basic Information, Manufacturing Base and Competitors
Table 68. Pharming Group NV Major Business
Table 69. Pharming Group NV Genetically Modified Drug Product and Services
Table 70. Pharming Group NV Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Pharming Group NV Recent Developments/Updates
Table 72. Pharming Group NV Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer Genetically Modified Drug Product and Services
Table 76. Pfizer Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Pfizer Competitive Strengths & Weaknesses
Table 79. Roche Basic Information, Manufacturing Base and Competitors
Table 80. Roche Major Business
Table 81. Roche Genetically Modified Drug Product and Services
Table 82. Roche Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Roche Recent Developments/Updates
Table 84. Roche Competitive Strengths & Weaknesses
Table 85. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 86. Abbott Laboratories Major Business
Table 87. Abbott Laboratories Genetically Modified Drug Product and Services
Table 88. Abbott Laboratories Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Abbott Laboratories Recent Developments/Updates
Table 90. Abbott Laboratories Competitive Strengths & Weaknesses
Table 91. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 92. Johnson & Johnson Major Business
Table 93. Johnson & Johnson Genetically Modified Drug Product and Services
Table 94. Johnson & Johnson Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Johnson & Johnson Recent Developments/Updates
Table 96. Johnson & Johnson Competitive Strengths & Weaknesses
Table 97. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 98. Merck & Co. Major Business
Table 99. Merck & Co. Genetically Modified Drug Product and Services
Table 100. Merck & Co. Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Merck & Co. Recent Developments/Updates
Table 102. Merck & Co. Competitive Strengths & Weaknesses
Table 103. Amgen Basic Information, Manufacturing Base and Competitors
Table 104. Amgen Major Business
Table 105. Amgen Genetically Modified Drug Product and Services
Table 106. Amgen Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Amgen Recent Developments/Updates
Table 108. Amgen Competitive Strengths & Weaknesses
Table 109. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 110. F. Hoffmann-La Roche Major Business
Table 111. F. Hoffmann-La Roche Genetically Modified Drug Product and Services
Table 112. F. Hoffmann-La Roche Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. F. Hoffmann-La Roche Recent Developments/Updates
Table 114. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
Table 115. Sanofi Basic Information, Manufacturing Base and Competitors
Table 116. Sanofi Major Business
Table 117. Sanofi Genetically Modified Drug Product and Services
Table 118. Sanofi Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Sanofi Recent Developments/Updates
Table 120. Sanofi Competitive Strengths & Weaknesses
Table 121. Novartis Basic Information, Manufacturing Base and Competitors
Table 122. Novartis Major Business
Table 123. Novartis Genetically Modified Drug Product and Services
Table 124. Novartis Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Novartis Recent Developments/Updates
Table 126. Novartis Competitive Strengths & Weaknesses
Table 127. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 128. Eli Lilly Major Business
Table 129. Eli Lilly Genetically Modified Drug Product and Services
Table 130. Eli Lilly Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Eli Lilly Recent Developments/Updates
Table 132. Eli Lilly Competitive Strengths & Weaknesses
Table 133. Takeda Basic Information, Manufacturing Base and Competitors
Table 134. Takeda Major Business
Table 135. Takeda Genetically Modified Drug Product and Services
Table 136. Takeda Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Takeda Recent Developments/Updates
Table 138. Takeda Competitive Strengths & Weaknesses
Table 139. Baxter Basic Information, Manufacturing Base and Competitors
Table 140. Baxter Major Business
Table 141. Baxter Genetically Modified Drug Product and Services
Table 142. Baxter Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Baxter Recent Developments/Updates
Table 144. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 145. GlaxoSmithKline Major Business
Table 146. GlaxoSmithKline Genetically Modified Drug Product and Services
Table 147. GlaxoSmithKline Genetically Modified Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Genetically Modified Drug Upstream (Raw Materials)
Table 149. Genetically Modified Drug Typical Customers
Table 150. Genetically Modified Drug Typical Distributors
LIST OF FIGURES
Figure 1. Genetically Modified Drug Picture
Figure 2. World Genetically Modified Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Genetically Modified Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Genetically Modified Drug Production (2018-2029) & (K Units)
Figure 5. World Genetically Modified Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Genetically Modified Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Genetically Modified Drug Production Market Share by Region (2018-2029)
Figure 8. North America Genetically Modified Drug Production (2018-2029) & (K Units)
Figure 9. Europe Genetically Modified Drug Production (2018-2029) & (K Units)
Figure 10. China Genetically Modified Drug Production (2018-2029) & (K Units)
Figure 11. Japan Genetically Modified Drug Production (2018-2029) & (K Units)
Figure 12. Genetically Modified Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 15. World Genetically Modified Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 17. China Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 22. India Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Genetically Modified Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Genetically Modified Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Genetically Modified Drug Markets in 2022
Figure 26. United States VS China: Genetically Modified Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Genetically Modified Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Genetically Modified Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Genetically Modified Drug Production Market Share 2022
Figure 30. China Based Manufacturers Genetically Modified Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Genetically Modified Drug Production Market Share 2022
Figure 32. World Genetically Modified Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Genetically Modified Drug Production Value Market Share by Type in 2022
Figure 34. Transgenic Animal
Figure 35. Transgenic Plant
Figure 36. World Genetically Modified Drug Production Market Share by Type (2018-2029)
Figure 37. World Genetically Modified Drug Production Value Market Share by Type (2018-2029)
Figure 38. World Genetically Modified Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Genetically Modified Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Genetically Modified Drug Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Genetically Modified Drug Production Market Share by Application (2018-2029)
Figure 44. World Genetically Modified Drug Production Value Market Share by Application (2018-2029)
Figure 45. World Genetically Modified Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Genetically Modified Drug Industry Chain
Figure 47. Genetically Modified Drug Procurement Model
Figure 48. Genetically Modified Drug Sales Model
Figure 49. Genetically Modified Drug Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Figure 1. Genetically Modified Drug Picture
Figure 2. World Genetically Modified Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Genetically Modified Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Genetically Modified Drug Production (2018-2029) & (K Units)
Figure 5. World Genetically Modified Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Genetically Modified Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Genetically Modified Drug Production Market Share by Region (2018-2029)
Figure 8. North America Genetically Modified Drug Production (2018-2029) & (K Units)
Figure 9. Europe Genetically Modified Drug Production (2018-2029) & (K Units)
Figure 10. China Genetically Modified Drug Production (2018-2029) & (K Units)
Figure 11. Japan Genetically Modified Drug Production (2018-2029) & (K Units)
Figure 12. Genetically Modified Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 15. World Genetically Modified Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 17. China Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 22. India Genetically Modified Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Genetically Modified Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Genetically Modified Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Genetically Modified Drug Markets in 2022
Figure 26. United States VS China: Genetically Modified Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Genetically Modified Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Genetically Modified Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Genetically Modified Drug Production Market Share 2022
Figure 30. China Based Manufacturers Genetically Modified Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Genetically Modified Drug Production Market Share 2022
Figure 32. World Genetically Modified Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Genetically Modified Drug Production Value Market Share by Type in 2022
Figure 34. Transgenic Animal
Figure 35. Transgenic Plant
Figure 36. World Genetically Modified Drug Production Market Share by Type (2018-2029)
Figure 37. World Genetically Modified Drug Production Value Market Share by Type (2018-2029)
Figure 38. World Genetically Modified Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Genetically Modified Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Genetically Modified Drug Production Value Market Share by Application in 2022
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Genetically Modified Drug Production Market Share by Application (2018-2029)
Figure 44. World Genetically Modified Drug Production Value Market Share by Application (2018-2029)
Figure 45. World Genetically Modified Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Genetically Modified Drug Industry Chain
Figure 47. Genetically Modified Drug Procurement Model
Figure 48. Genetically Modified Drug Sales Model
Figure 49. Genetically Modified Drug Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
